Selected article for: "case control and control case"
Author: Robinson, Lary A; Smith, Prudence; SenGupta, Dhruba J; Prentice, Jennifer L; Sandin, Ramon L
Title: Molecular analysis of sarcoidosis lymph nodes for microorganisms: a case–control study with clinical correlates
  • Document date: 2013_12_21
    • ID: 3unap1o9_160
    Snippet: Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 *Give information separately for cases and controls in case-control studies and, if applicable, for exposed and .....
    Document: Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 *Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.

    Search related documents:
    Co phrase search for related documents
    • cross sectional study and original study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cross sectional study and present article: 1, 2, 3, 4, 5
    • cross sectional study and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • cross sectional study and STROBE checklist: 1, 2, 3, 4
    • cross sectional study and unexposed exposed group: 1, 2
    • funding source and original study: 1, 2, 3, 4, 5, 6, 7
    • funding source and present article: 1, 2, 3, 4, 5, 6, 7
    • funding source and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • funding source and separately information: 1, 2, 3, 4, 5, 6, 7
    • methodological background and present study: 1
    • original study and present article: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • original study and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • original study and separately information: 1, 2, 3, 4, 5, 6, 7
    • present article and separately information: 1, 2, 3, 4, 5, 6, 7
    • present article and web site: 1
    • present study and separately information: 1, 2, 3, 4, 5, 6, 7
    • present study and STROBE checklist: 1, 2
    • present study and unexposed exposed group: 1
    • STROBE checklist and transparent reporting: 1